Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy
Hormone and Metabolic Research · 01.08.2026 · 58 (08) · 299-310
DOI: 10.1055/a-2901-3276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.08.2026. Verfasst von Ali Zeynettin und 2 weiteren Autor:innen. Beteiligte Einrichtung: İzmir Bozyaka Education and Research Hospital, Department of Internal Medicine, Türkiye, İzmir. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Anti-Inflammatory Agents, Dyslipidemias, Hyperglycemia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AbstractIn type 2 diabetes, hyperglycaemia usually clusters with atherogenic dyslipidaemia and low-grade inflammation; yet, these axes may dissociate in some patients. We aimed to estimate the prevalence of a normolipidemic dysglycemia phenotype in adults with type 2 diabetes and characterise its clinical–biochemical profile within an analytical window free of lipid-lowering and chronic anti-inflammatory/immunomodulatory therapy. In this retrospective, cross-sectional study, we analysed records of 1,046 adults aged 25–60 years with type 2 diabetes from a tertiary care hospital between 2020 and 2024. Individuals with other diabetes types, acute inflammatory conditions, malignancy, advanced organ failure and non-euthyroid status were excluded. Normolipidemic dysglycemia was defined as glycated hemoglobin≥64 mmol/mol with low-density lipoprotein cholesterol
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- İzmir Bozyaka Education and Research Hospital, Department of Internal Medicine, Türkiye, İzmir.
- Ministry of Health İzmir City Hospital, Department of Internal Medicine, Türkiye, İzmir.
ORCID-Profile: Ali Zeynettin
Zitieren
APA
Zeynettin, A., Balikci, O., & Demir, İ. (2026). Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy. Hormone and Metabolic Research, 58(08), 299-310. https://doi.org/10.1055/a-2901-3276
Vancouver
Zeynettin A, Balikci O, Demir İ. Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy. Hormone and Metabolic Research. 2026;58(08):299-310. doi:10.1055/a-2901-3276
BibTeX
@article{Zeynettin2026,
author = {Zeynettin, Ali and Balikci, Orhan and Demir, İsmail},
title = {Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy},
journal = {Hormone and Metabolic Research},
year = {2026},
volume = {58},
number = {08},
pages = {299--310},
doi = {10.1055/a-2901-3276}
}
EUVIMED